Nuvectis Pharma Raises $15 Million and In-Licenses Exclusive Worldwide Rights to Novel Selective HSF1 Pathway Inhibitor from the CRT Pioneer Fund

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition